Abstract

Deep convolutional neural networks are favored methods that are widely used in medical image processing due to their demonstrated performance in this area. Recently, the emergence of new lung diseases, such as COVID-19, and the possibility of early detection of their symptoms from chest computerized tomography images has attracted many researchers to classify diseases by training deep convolutional neural networks on lung computerized tomography images. The trained networks are expected to distinguish between different lung indications in various diseases, especially at the early stages. The purpose of this study is to introduce and assess an efficient deep convolutional neural network, called AFEX-Net, that can classify different lung diseases from chest computerized tomography images. We designed a lightweight convolutional neural network called AFEX-Net with adaptive feature extraction layers, adaptive pooling layers, and adaptive activation functions. We trained and tested AFEX-Net on a dataset of more than 10,000 chest computerized tomography slices from different lung diseases (CC dataset), using an effective pre-processing method to remove bias. We also applied AFEX-Net to the public COVID-CTset dataset to assess its generalizability. The study was mainly conducted based on data collected over approximately six months during the pandemic outbreak in Afzalipour Hospital, Iran, which is the largest hospital in Southeast Iran. AFEX-Net achieved high accuracy and fast training on both datasets, outperforming several state-of-the-art convolutional neural networks. It has an accuracy of and on the CC and COVID-CTset datasets, respectively, with a learning speed that is 3 times faster compared to similar methods due to its lightweight structure. AFEX-Net was able to extract distinguishing features and classify chest computerized tomography images, especially at the early stages of lung diseases. The AFEX-Net is a high-performing convolutional neural network for classifying lung diseases from chest CT images. It is efficient, adaptable, and compatible with input data, making it a reliable tool for early detection and diagnosis of lung diseases.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call